Check-Cap has become the latest firm to target an initial public offering: it plans to sell 1.2 million shares at $10-12 each, giving it around $13m at the midpoint. If successful, it will trade on the Nasdaq under the ticker symbol CHEK.
The Mount Carmel, Israel-based company has developed an ingestible X-ray imaging capsule for colorectal cancer screening, which creates a 3D...





